The inhibition of β-catenin/AMPK/SIRT1 was also shown in SCLC xenografts as well as attenuation of expression or activity of rate-limiting enzyme in aerobic oxidation progression. The gene discussed is SIRT1; the disease is small cell lung carcinoma.